$GERN
GERON CORP Stock $gern

$gern Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000110465914033482 Filed on May 01, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$340.0K	$470.0K	$765.0K
YoY Change	203.57%	-38.56%	-39.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.850M	$3.990M	$4.750M
YoY Change	12.24%	-16.0%	-6.31%
% of Gross Profit
Research & Development	$5.151M	$5.211M	$7.999M
YoY Change	7.16%	-34.85%	-47.05%
% of Gross Profit
Depreciation & Amortization	$10.00K	$20.00K	$140.0K
YoY Change	-91.67%	-85.71%	-44.0%
% of Gross Profit
Operating Expenses	$5.151M	$9.205M	$12.75M
YoY Change	-43.25%	-27.8%	-36.79%
Operating Profit		-$8.731M	-$11.99M
YoY Change		-27.15%	-36.65%
Interest Expense	-$70.00K	$290.0K	$90.00K
YoY Change	-450.0%	222.22%	-50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$8.730M	-$8.440M	-$11.90M
YoY Change	-2.46%	-29.08%	-36.5%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$8.730M	-$8.440M	-$11.90M
YoY Change	-2.43%	-29.06%	-36.51%
Net Earnings / Revenue	-2567.65%	-1795.74%	-1555.16%
Basic Earnings Per Share
Diluted Earnings Per Share	-$55.71K	-$58.83K	-$92.98K
COMMON SHARES
Basic Shares Outstanding	156.9M shares		130.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$140.3M	$145.2M	$79.00M
YoY Change	98.16%	83.8%	-33.84%
Cash & Equivalents	$9.520M	$11.32M	$15.51M
Short-Term Investments	$130.8M	$133.9M	$63.50M
Other Short-Term Assets	$1.000M	$1.000M	$1.600M
YoY Change	-16.67%	-37.5%	-27.27%
Inventory
Prepaid Expenses	$205.0K		$822.0K
Receivables
Other Receivables
Total Short-Term Assets	$142.6M	$147.7M	$81.58M
YoY Change	96.87%	81.03%	-33.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.00K	$77.00K	$866.0K
YoY Change	-89.4%	-91.11%	-21.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.500M	$7.500M
YoY Change
Other Assets	$200.0K	$200.0K	$400.0K
YoY Change	-50.0%	-50.0%	-55.56%
Total Long-Term Assets	$6.747M	$7.732M	$1.276M
YoY Change	588.47%	505.96%	-93.18%
TOTAL ASSETS
Total Short-Term Assets	$142.6M	$147.7M	$81.58M
Total Long-Term Assets	$6.747M	$7.732M	$1.276M
Total Assets	$149.3M	$155.4M	$82.85M
YoY Change	103.43%	87.57%	-41.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.223M	$1.520M	$1.669M
YoY Change	4.0%	-8.93%	-38.19%
Accrued Expenses	$1.057M	$1.286M	$2.591M
YoY Change	-22.16%	-50.37%	-65.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.756M	$4.516M	$6.793M
YoY Change	-4.96%	-33.52%	-34.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.756M	$4.516M	$6.793M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.800M	$4.500M	$6.800M
YoY Change	-4.0%	-33.82%	-33.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$909.9M	-$901.2M	-$866.3M
YoY Change	3.97%	4.03%
Common Stock	$1.055B	$1.052B	$942.3M
YoY Change	11.75%	11.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$144.6M	$150.9M	$76.06M
YoY Change
Total Liabilities & Shareholders Equity	$149.3M	$155.4M	$82.85M
YoY Change	103.43%	87.57%	-41.32%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$8.730M	-$8.440M	-$11.90M
YoY Change	-2.43%	-29.06%	-36.51%
Depreciation, Depletion And Amortization	$10.00K	$20.00K	$140.0K
YoY Change	-91.67%	-85.71%	-44.0%
Cash From Operating Activities	-$5.150M	-$9.510M	-$16.23M
YoY Change	-34.97%	-41.4%	-2.17%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$34.00K
YoY Change	-100.0%	-100.0%	-59.52%
Acquisitions
YoY Change
Other Investing Activities	$3.240M	-$89.78M	$9.690M
YoY Change	163.41%	-1026.52%	-50.56%
Cash From Investing Activities	$3.240M	-$89.78M	$9.660M
YoY Change	167.77%	-1029.4%	-50.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$97.62M	$11.00K
YoY Change		887354.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	110.0K	97.62M	10.00K
YoY Change	120.0%	976100.0%
NET CHANGE
Cash From Operating Activities	-5.150M	-9.510M	-16.23M
Cash From Investing Activities	3.240M	-89.78M	9.660M
Cash From Financing Activities	110.0K	97.62M	10.00K
Net Change In Cash	-1.800M	-1.670M	-6.560M
YoY Change	-72.97%	-74.54%	-324.66%
FREE CASH FLOW
Cash From Operating Activities	-$5.150M	-$9.510M	-$16.23M
Capital Expenditures	$0.00	$0.00	$34.00K
Free Cash Flow	-$5.150M	-$9.510M	-$16.26M
YoY Change	-34.73%	-41.53%	-2.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	795000	USD
CY2014Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	141423000	USD
CY2014Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	8834000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8834000	USD
CY2014Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	25875000	shares
CY2014Q1	gern	Equity Issuance Per Share Amount At Public Offering EquityIssuancePerShareAmountAtPublicOffering	4.00
CY2014Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	96805000	USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22063000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15505000	USD
CY2014Q1	gern	Gross Unrealized Losses Available For Sale Securities GrossUnrealizedLossesAvailableForSaleSecurities	102000	USD
CY2013Q4	gern	Gross Unrealized Gains Available For Sale Securities GrossUnrealizedGainsAvailableForSaleSecurities	5000	USD
CY2013Q4	gern	Gross Unrealized Losses Available For Sale Securities GrossUnrealizedLossesAvailableForSaleSecurities	19000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	52234000	USD
CY2014Q1	gern	Gross Unrealized Gains Available For Sale Securities GrossUnrealizedGainsAvailableForSaleSecurities	12000	USD
CY2014Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	141333000	USD
CY2014Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	83000	USD
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P1Y
CY2014Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.00	pure
CY2014Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	1.361	pure
CY2014Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0013	pure
CY2014Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P1Y
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	41007000	USD
CY2013Q4	gern	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAggregateLosses	19000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	41007000	USD
CY2013Q4	gern	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLoss	19000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	120170000	USD
CY2014Q1	gern	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAggregateLosses	102000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	120170000	USD
CY2014Q1	gern	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLoss	102000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	143000	USD
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.00	pure
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	0.844	pure
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0013	pure
CY2014Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	313000	USD
CY2013Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	839000	USD
CY2014Q1	gern	Reclassification Of Deposits To Other Current Assets ReclassificationOfDepositsToOtherCurrentAssets	-4000	USD
CY2014Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-76000	USD
CY2013Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-22000	USD
CY2014Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1382000	USD
CY2014Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	11000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3946000	USD
CY2013Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	94000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11985000	USD
CY2013Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	25000	USD
CY2013Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	81000	USD
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	GERON CORP
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000886744
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12990000	USD
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	156938288	shares
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	795000	USD
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	52234000	USD
CY2013Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	564000	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	474000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	67057000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92000	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	195000	USD
CY2013Q4	us-gaap	Assets Assets	67344000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1397000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1783000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	367000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7587000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	131000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	952403000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-892763000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	59757000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67344000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155408000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	150892000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4516000	USD
CY2014Q1	us-gaap	Assets Assets	155408000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	147676000	USD
CY2013Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7999000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4751000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	12750000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	9205000	USD
CY2013Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	18000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-11897000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9505000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	127982931	shares
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	143465818	shares
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-8440000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8731000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-22000	USD
CY2014Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	15000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11919000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8516000	USD
CY2014Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-606000	USD
CY2013Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	142000	USD
CY2013Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-328000	USD
CY2013Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	104000	USD
CY2013Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	24000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1348000	USD
CY2013Q1	gern	Amortization Related To Share Based Matching Contributions AmortizationRelatedToShareBasedMatchingContributions	103000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-345000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-6491000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16227000	USD
CY2014Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	65000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	104000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	18007000	USD
CY2013Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	27595000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	9658000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	11000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6558000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-89781000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-1666000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	97620000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11324000	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	107144000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5596655	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13949	shares
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 13.5pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On a regular basis, management evaluates these estimates and assumptions. Actual results could differ from those estimates.</font></p> </div>
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	795000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P4Y
CY2013Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10285000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	10285000	USD
CY2013Q4	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	795000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	52248000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1641000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1348000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77000	USD
CY2014Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	191000	USD
CY2014Q1	gern	Licenses And Royalty Revenue LicensesAndRoyaltyRevenue	474000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1520000	USD
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1556000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1286000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	157000	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1052028000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-901203000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-90000	USD
CY2014Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5211000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3994000	USD
CY2014Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	224000	USD
CY2014Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	83000	USD
CY2014Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	16000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-76000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1641000	USD
CY2014Q1	gern	Amortization Related To Share Based Matching Contributions AmortizationRelatedToShareBasedMatchingContributions	12000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	646000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2534000	USD
CY2014Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17363000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	97620000	USD
CY2014Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	7464000	USD

Files In Submission

Name	View Source	Status
0001104659-14-033482-index-headers.html	Edgar Link	pending
0001104659-14-033482-index.html	Edgar Link	pending
0001104659-14-033482.txt	Edgar Link	pending
0001104659-14-033482-xbrl.zip	Edgar Link	pending
a14-9301_110q.htm	Edgar Link	pending
a14-9301_1ex31d1.htm	Edgar Link	pending
a14-9301_1ex31d2.htm	Edgar Link	pending
a14-9301_1ex32d1.htm	Edgar Link	pending
a14-9301_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gern-20140331.xml	Edgar Link	completed
gern-20140331.xsd	Edgar Link	pending
gern-20140331_cal.xml	Edgar Link	unprocessable
gern-20140331_def.xml	Edgar Link	unprocessable
gern-20140331_lab.xml	Edgar Link	unprocessable
gern-20140331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GERN
GERON CORP Stock $gern

2014 Q2 Form 10-Q Financial Statement

#000110465914033482 Filed on May 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GERN GERON CORP Stock $gern

2014 Q2 Form 10-Q Financial Statement

#000110465914033482 Filed on May 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GERN
GERON CORP Stock $gern